Cysticercosis of the central nervous system: How should it be managed?

Current Opinion in Infectious Diseases

Volumn 24, Issue 5, 2011, Pages 423-427

  Garcia, Hector H ^a,b   Gonzalez, Armando E ^c   Gilman, Robert H ^d  

^a Universidad Peruana Cayetano Heredia   (Peru)

^b INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^c UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

albendazole; cysticercosis; praziquantel; Taenia solium; taeniasis; treatment

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; PRAZIQUANTEL;

ANTICONVULSANT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; EXTRAPARENCHYMAL NEUROCYSTICERCOSIS; GRAY MATTER; HUMAN; IMMUNE RESPONSE; INTRAPARENCHYMAL BRAIN CYSTICERCOSIS; MINIMALLY INVASIVE SURGERY; NEUROCYSTICERCOSIS; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PROGNOSIS; REVIEW; SEIZURE; SYMPTOMATOLOGY; TAENIA SOLIUM;

ANIMALS; ANTIPARASITIC AGENTS; DISEASE MODELS, ANIMAL; HUMANS; NEUROCYSTICERCOSIS; SWINE; TAENIA SOLIUM;

EID: 80052481328     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32834a1b20     Document Type: Review

References (42)

1. Montano SM, Villaran MV, Ylquimiche L, et al. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 2005; 65:229-233.
2. Goel D, Dhanai JS, Agarwal A, et al. Neurocysticercosis and its impact on crude prevalence rate of epilepsy in an Indian community. Neurol India 2010; 59:37-40.
3. Medina MT, Aguilar-Estrada RL, Alvarez A, et al. Reduction in rate of epilepsy from neurocysticercosis by community interventions: The Salama, Honduras Study. Epilepsia 2011; 52:1177-1185.
4. Del Brutto OH, Santibanez R, Idrovo L, et al. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 2005; 46:583-587. (Pubitemid 40470684)
5. Ndimubanzi PC, Carabin H, Budke CM, et al. A systematic review of the frequency of neurocysticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 2010; 4:e870.
6. Ciampi de Andrade D, Rodrigues CL, Abraham R, et al. Cognitive impairment and dementia in neurocysticercosis: a cross-sectional controlled study. Neurology 2010; 74:1288-1295.
7. Mahanty S, Garcia HH. Cysticercosis and neurocysticercosis as pathogens affecting the nervous system. Prog Neurobiol 2010; 91:172-184.
8. Flisser A. Taeniasis and cysticercosis due to Taenia solium. Prog Clin Parasitol 1994; 4:77-116.
9. Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005; 4:653-661. (Pubitemid 41317300)
10. Nash TE, Singh G, White AC, et al. Treatment of neurocysticercosis: current status and future research needs. Neurology 2006; 67:1120-1127. (Pubitemid 44563815)
11. Garcia HH, Gonzalez AE, Rodriguez S, et al. Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology 2010; 75:654-658.
12. McArthur WP. Cysticercosis as seen in the British army with special reference to the production of epilepsy. Trans R Soc Trop Med Hyg 1934; 27:343-363.
13. Dixon HB, Lipscomb FM. Cysticercosis: an analysis and follow-up of 450 cases. Medical Research Council Special Report Series 299. London: HMSO; 1961.
14. Estanol B, Corona T, Abad P. A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry 1986; 49:1131-1134. (Pubitemid 16028694)
15. Escobar A. The pathology of neurocysticercosis. In: Palacios E, Rodriguez-Carbajal J, Taveras JM, editors. Cysticercosis of the central nervous system. Springfield, IL: Charles C. Thomas; 1983. pp. 27-54.
16. Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand 1991; 84:465-470.
17. Rajshekhar V, Chandy MJ. Solitary cysticercus granuloma: the disappearing lesion. Chennai: Orient Longman; 2000.
18. Rangel R, Torres B, Del BrutoO, Sotelo J. Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg 1987; 36:387-392. (Pubitemid 17057543)
19. Garcia HH, Del Brutto OH. Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Peru. Neurology 1999; 53:1582-1584. (Pubitemid 29491959)
20. Fleury A, Carrillo-Mezo R, Flisser A, et al. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 2010; 9:123-133.
21. Proano JV, Madrazo I, Avelar F, et al. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001; 345:879-885.
22. Del Brutto OH, Santibanez R, Noboa CA, et al. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992; 42:389-392.
23. Garcia HH, Gonzalez AE, Gilman RH, et al. Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis. Am J Trop Med Hyg 2002; 66:427-430. (Pubitemid 34810499)
24. Suastegui Roman RA, Soto-Hernandez JL, Sotelo J. Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study. J Neurosurg 1996; 84:629-633. (Pubitemid 26104231)
25. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004; 350:249-258. (Pubitemid 38067637)
26. Sotelo J, del Brutto OH, Penagos P, et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 1990; 237:69-72. (Pubitemid 20152071)
27. Corona T, Lugo R, Medina R, Sotelo J. Single-day praziquantel therapy for neurocysticercosis. N Engl J Med 1996; 334:125.
28. Del Brutto OH, Roos KL, Coffey CS, Garcia HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006; 145:43-51. (Pubitemid 46780606)
29. Vazquez ML, Jung H, Sotelo J. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology 1987; 37:1561-1562. (Pubitemid 17132348)
30. Agapejev S, Meira DA, Barraviera B, et al. Neurocysticercosis: treatment with albendazole and dextrochloropheniramine. Trans R Soc Trop Med Hyg 1989; 83:377-383. (Pubitemid 19163230)
31. Gongora-Rivera F, Soto-Hernandez JL, Gonzalez Esquivel D, et al. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology 2006; 66:436-438. (Pubitemid 43739954)
32. Guo DM, Xie SP, Jia JP. [Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2003; 21:187-188.
33. Kaur S, Singhi P, Singhi S, Khandelwal N. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J 2009; 28:403-406.
34. Garcia HH, Lescano AG, Lanchote V, et al. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br J Clin Pharmacol 2011; 72:77-84.
35. Rajshekhar V. Surgical management of neurocysticercosis. Int J Surg 2010; 8:100-104.
36. Torres-Corzo JG, Tapia-Perez JH, Vecchia RR, et al. Endoscopic management of hydrocephalus due to neurocysticercosis. Clin Neurol Neurosurg 2010; 112:11-16.
37. Gonzales AE,Garcia HH, Gilman RH, et al. Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am J Trop Med Hyg 1996; 54:391-394. (Pubitemid 26126648)
38. Gonzalez AE, Cama V, Gilman RH, et al. Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg 1990; 43:194-199. (Pubitemid 20268888)
39. Gonzalez AE, Gauci CG, Barber D, et al. Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg 2005; 72:837-839. (Pubitemid 41278809)
40. Verastegui M, Gonzalez A, Gilman RH, et al. Experimental infection model for Taenia solium cysticercosis in swine. Cysticercosis Working Group in Peru. Vet Parasitol 2000; 94:33-44.
41. Gonzalez AE, Falcon N, Gavidia C, et al. Time-response curve of oxfendazole in the treatment of swine cysticercosis. Am J Trop Med Hyg 1998; 59:832-836. (Pubitemid 28524547)
42. Flisser A, Gauci CG, Zoli A, et al. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun 2004; 72:5292-5297. (Pubitemid 39223416)